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JUVENILE DERMATOMYOSITIS - A CASE REPORT WITH REVIEW
ON ORAL MANIFESTATIONS AND ORAL HEALTH
CONSIDERATIONS.
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VRUTTI SHAH, BDS, KRISHNA SHAH, BDS

ABSTRACT
Juvenile Dermatomyositis is the most common inflammatory myositis in children, distinguished by
proximal muscle weakness, a characteristic rash and Gottron s papules. The oral lesions most
commonly manifest as diffuse stomatitis and pharyngitis with halitosis. We report a case of an 8
year old male with proximal muscle weakness of all four limbs, rash, Gottron s papules and oral
manifestations. Oral health professionals must be aware of the extraoral and intraoral findings of
this rare, but potentially life threatening autoimmune disease of childhood, for early diagnosis,
treatment, prevention of long-term complications and to improve the prognosis and hence, the
quality of life for the patient.
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INTRODUCTION
Juvenile dermatomyositis (JDM) is an

and pain; a more acute onset occurs in

inflammatory, chronic autoimmune multisystem

approximately one third of children (Cassidy &

vasculopathy affecting primarily the skin and

Lindsley, 2010). The incidence reported in a

muscle, causing symmetric proximal weakness

recent population- based study confirmed an

and characteristic skin rash (Chari & Laude,

incidence of 9.63 cases per million persons

2000).JDM represents a type of idiopathic

(Tanaka & Geist,2012). Our PubMed literature

myositis, which also comprises of polymyositis,

search for search words juvenile ,

necrotizing autoimmune myopathy and

dermatomyositis and oral manifestations

sporadic inclusion body myositis (Malik, Hayat

revealed scanty literature, out of which only 53

& Kalia, 2016). Onset is usually insidious, with

articles discuss the oral manifestations of the

development of progressive muscle weakness

disease.
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The earliest event in JDM pathogenesis is the

Laude, 2000; Lowry & Pilkington, 2009).

immune attack on muscle capillary

Calcinosis, which is the abnormal deposition of

endothelium, infiltration of plasmacytoid

insoluble calcium salts within the skin,

dendritic cells with a resulting type I interferon

subcutaneous tissue, myofascia, or muscle

response, and upregulation of major

occurs in 20 40% of patients (Lowry &

histocompatibility (MHC) class I expression on

Pilkington, 2009; Rider & Jones, 2013).

the surface of myofibers (Cassidy & Lindsley,

Gower s sign which is difficulty in climbing

2010).

stairs and also in raising from floor to standing

The clinical presentation of JDM was first

on the legs to attain a standing position and

described in 1887. Later, five criteria were

Trendelenburg sign which is a diagnostic test

given by Bohan and Peter in 1975 aid in its

of function and dysfunction of hip become

diagnosis. A diagnosis of probable JDM

positive when there is abductor weakness, as

requires the presence of the pathognomonic

in poliomyelitis or muscular dystrophies

rash (Gottron papules over the extensor

(Hoeltzel, Oberle, Robinson, Agarwal, Rider,

surfaces of the finger joints, elbows, knees or

2014; Agarwal, 2003).

ankles) or the heliotrope rash and two of the

The oral lesions most commonly manifest as

other criteria; definite JDM requires the

diffuse stomatitis and pharyngitis with halitosis.

characteristic rash with three other criteria. In

Telangiectatic lesions on the vermilion border

general, the first two criteria (i.e., proximal

of lips and cheeks may also occur. Capillary

muscle weakness and classic rash) are almost

abnormalities in the gingiva described in five

always present; criterion 3 (i.e., elevated serum

patients with juvenile dermatomyositis (JDM)

levels of muscle enzymes), 4 (i.e.,

were described as analogous to the

electromyographic changes), and 5 (i.e.,

periungualtelangiectases that are seen in the

histopathological changes) provide additional

nail beds of patients with this disease,

laboratory support for the diagnosis (Bohan &

suggesting that oral symptoms are important

Peter, 1975).

diagnostic markers (Vasudevan,

The onset of JDM is often characterized by

Vaidyalingam& Nair, 1997). Pharyngeal,

fever in the range of 38º C to 40º C followed by

hypopharyngeal, or palatal involvement,

Malaise, anorexia, and weight loss (Cassidy

causing dysphonia, dysphagia, nasalized

&Lindsley, 2010). Cutaneous manifestations

speech, and regurgitation of liquids through the

include the heliotrope rash (purple pink in color

nose can be seen in 25% of the patients, due

over the eyelids, periorbital oedema, Gottron s

to loss of pharyngo-esophageal muscle tone

papules (skin thickening over the extensor

and abnormal hyolaryngeal excursion (Deepa,

surfaces of joints) and hypertrichosis (Chari &
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Kumar, Chawla, Patil, 2015; Marvi, Chung &

Juvenile Dermatomyositis and initiated

Fiorentino, 2012; Carstens & Schmidt, 2013).

treatment for the same. His parents reported
that the patient had difficulties in climbing stairs

Oral health care providers may play a primary

and standing or running for a longer period of

role in the diagnosis of dermatomyositis. The

time; difficulty in rising from sitting position;

importance of investigations in this area is

problems in swallowing solid food with

determined by the fact that, regardless of the

occasional regurgitation and difficulty in

restricted number of dermatomyositis patients

chewing.

with oral involvement, the disorder may have
acute evolution and may progress with a fatal

General physical examination revealed

outcome, or in other cases, with gradual

Gower s sign and Trendelenburg sign,

involvement leads to serious invalidity and in

Moderate built, low grade fever, the patient had

the final stage needs special care (Vasudevan,

difficulty entering the dental chair due to limited

Vaidyalingam, Bhaskaran,1997).

range of motion and hence, had to ask his
parents to assist him to get up on the chair by

CASE REPORT

putting their hands under his shoulder blade to

An 8 year old male reported to the Department

lift him up. Extraoral examination revealed,

of Oral Medicine and Radiology, College of

hypertrichosis and characteristic erythematous

Dental Sciences and Research Centre, Bopal,

rash on the palmar surfaces of hands and

Ahmedabad, with the chief complaint of dental

Gottron s papules on elbows and knees. Figure

caries. Medical history revealed that the patient

1 (A - C).

complained of mild fever, skin rash and

Intraoral examination revealed poor oral

weakness, and was initially diagnosed as a

hygiene with severe halitosis, retention of food

case of virally caused muscle fatigue 2 years

in the vestibule and the teeth due to difficulty in

before. But since the symptoms worsened and

swallowing, leading to drooling and leakage of

the patient could not write or lift things, had

liquid or food while eating. He also felt fatigued

difficulty in holding a comb or a tooth-brush

while rinsing his mouth after meals, due to

himself, 6 months later they consulted a

which he was suffering from Early Childhood

physiotherapist. A year later, after no resolution

Caries. The patient attributed this to his

in movement limitations and additional

inability to brush properly due to proximal

complaints of dysphagia, increased intensity of

muscle weakness of upper limbs. The

erythematous rash and papules on the elbows

masseter was tender on palpation, suggestive

and knees, they consulted a general

of myositis, possibly secondary to JDM.

practitioner, who later referred them to a

Temporomandibular joint function and

rheumatologist, who diagnosed it as a case of
54
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mandibular movements were limited, with pain

oral examination revealed no other

during mouth opening, in the pre-auricular

abnormality. The gingival tissue was normal

region. However, the remainder of the child's

and without inflammation.

Figure1 A

Figure 1 B

Gottron s papules

Hypertrichosis

Figure 1 C
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Radiographic findings show that 36 and 46

responded to the treatment so the dose of

were not erupted suggestive of delayed

steroids was tapered by 5mg after every 6

eruption of permanent teeth. Also, there was

weeks and then reduced by 1mg after every

no root resorption noted in deciduous central

4 weeks. Currently the patient is on

incisors suggestive of delayed root

maintenance dose and takes prednisolone

resorption of deciduous teeth.

5mg/day and 0.4 mg methotrexate IV per

Laboratory investigations showed that the

week. Figure 2 (A & B)

Serum Creatine phosphokinase levels were

The patient was practicing physiotherapy at

elevated and there was presence of Jo-1

home as per the guidance of the

autoantibodies in the serum.

pediatrician, and noted significant

Electromyography was suggestive of motor

improvement in the range of motion of the

axonal neuropathy. MRI findings were

limbs. Our patient showed significant

consistent with inflammatory myopathy.

regression of symptoms due to early

Dental rehabilitation was done after

diagnosis, with reduction in the

obtaining CBC and platelet counts, without

hypertrichosis and erythematous rashes on

any adverse reactions to local anesthetics.

the hands, along with improvement in the

Even though not noted on the radiograph,

movements, enabling him to climb the stairs

pulpal calcification was noted in mesiolingual

and get up from a sitting position without any

canal of 74, 54 and 64 (FDI tooth numbering

difficulty. Patient is kept on follow-up

system) during pulpectomy. Bite blocks were

regularly at 3 month intervals.

used to assist in restorative therapy, since
the patient could not open the mouth for

DISCUSSION

prolonged duration, owing to masseter

Dermatomyositis is a multi-system disease

involvement. Patient was advised to

characterized by vasculopathy of the skin

consume pureed and soft texture foods to

and/or muscles causing subacute

manage dysphagia. Oral prophylaxis was

progressive, proximal muscle weakness and

done, and patient was instructed to use

typical skin rashes, with an incidence of 3.2

power brush to maintain a meticulous oral

per million children per year (Carstens &

hygiene.

Schmidt, 2013); (Neto & Goldenstein-

Management under the rheumatologist

Schainberg, 2010). JDM is thought to be the

consisted of high-dose prednisone, i.e.

result of environmental triggers in genetically

30mg/day in divided doses of 10mg and

susceptible individuals, leading to immune

20mg and 0.7mg methotrexate IV per week

dysfunction and specific tissue responses.

for steroid-sparing effect. The patient
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Cases of infections with coxsackievirus,

relia, and Leishmania preceding the onset of

influenza, Group A Streptococcus,

JDM have been documented (Cassidy &

Toxoplasmosis, parvovirus, hepatitis B, Bor-

Lindsley, 2010).

Figure 2 A: Regression of hypertrichosis.
Figure 2 B: Decreased intensity of erythematous rash.
Dermatomyositis has a bimodal age

can be differentiated from that of JDM by its

distribution: one peak occurs between 5 14

severity, greater elevation of serum levels of

years of age and a second larger peak occurs

muscle enzymes and histological examination

between 45 64 years of age (Carstens &

of muscle (Cassidy & Lindsley, 2010).

Schmidt, 2013). In our report, the age at the

Bohan and Peter s (1975) criteria confirms a

onset of the disease is 6 years which is in

definite diagnosis of juvenile dermatomyositis

congruence with the literature. Age at onset

for our patient.

and the sex ratio of Juvenile Polymyositis (PM)

The classic heliotrope rash occurs over the

are comparable to JDM. But in PM, there are

upper eyelids as a violaceous, reddish purple

no associated cutaneous abnormalities.

suffusion. Pharyngeal, hypopharyngeal, and

Heliotrope rash, periorbital edema and Gottron

palatal muscles are frequently affected, leading

papules are present only in children with JDM,

to difficulty in swallowing i.e. dysphagia.

whereas linear extensor erythema is present in

Dysphonia (weakness of the voice or a gurgly

both JDM and SLE. Myositis occurs in systemic

voice quality) and nasal speech are also

scleroderma and juvenile chronic arthritis, but

frequent signs. Regurgitation of liquids through
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the nose increases the threat of aspiration in

mycophenolatemofetil (MMF), cyclosporine,

these children (Cassidy & Lindsley, 2010). Our

tacrolimus and intravenous immunoglobulin

patient had characteristic rash on the palmar

(IVIg) (Robinson, Hoeltzel, Wahezi, et al.,

surfaces of hands and Gottron s papules along

2014); (Hamlin, Jean & Shelton, 1984). Our

with proximal muscle weakness. In laboratory

patient was receiving 30mg/day prednisolone

findings, there is elevation of muscle enzymes

in divided doses of 10mg and 20mg and 0.7mg

(Saghafi, Rezaieyazdi & Hashemzadeh, 2014).

methotrexate IV per week for steroid-sparing

CPK was elevated in this case. Dysphagia and

effect. Physical training and rehabilitation

esophageal dysmotility are common in children

should be started early, maintained throughout

with JDM (Deepa et al., 2015). Our patient

the treatment (Moghadam-Kia, Aggarwal &

complained of difficulty in swallowing.

Oddis, 2015).

Similar to the experience reported by Hamlin C

Kim, El-Hallak, Dedeoglu, et al., (2009)

and Shelton J, extractions in our patient were

suggest that an aggressive treatment to obtain

accomplished with local anesthetic without any

rapid control of muscle weakness and

difficulty (Martin, Li & Wedderburn, 2012).

inflammation significantly improves the

Agents used for the management of myositis

prognosis and reduces the risk of

include glucocorticoids and traditional

complications related to the disease. Our

immunosuppressive or immunomodulatory

findings are compatible with other reports

agents such as methotrexate, azathioprine,

showing JDM.

Table 1: Oro-facial manifestations of JDM
Oro-facial manifestations secondary to JDM

Oro-facial manifestations primarily due to JDM

1.

1. Heliotrope rash

1. Poor oral hygiene

2.
3.

2. Periorbital edema
3. Hypertrichosis

2. Halitosis
3. Dental caries

4.

4. Stomatitis, Pharyngitis

4. Limited range of motion of TMJ

5.
6.

5. Gingival telangiectases
6.
Tenderness
of
muscles
mastication
7. Dysphonia
8. Dysphagia

7.
8.

9.

of

5. Nasalized speech
6. Regurgitation of liquids through the nose
7. Over-retained deciduous teeth
8. Delayed eruption

9. Soft tissue calcifications

9. Features secondary to long-term immunesuppressive therapy
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Table 2: Dental treatment considerations for patients
with Juvenile Dermatomyositis
1.

Advise to maintain proper oral hygiene

2.

Advise power brush

3.

Advice limited mouth opening*

4.

Hot water fomentation*

5.

Soft diet*

6.

Short appointments

7.

Use bite blocks

8.

Regular follow up

*for muscle pain

CONCLUSION
Juvenile dermatomyositis is a rare and potentially severe disease which requires early diagnosis
and management, hence the need to present an already diagnosed case. The aim of
presenting this case is to make doctors aware of this condition to aid in early diagnosis of a
patient suffering from such myopathy, which can be presented in a dental clinic with the oro-facial
manifestations. Juvenile dermatomyositis has the potential to have a significant adverse effect upon
the lifestyle of the patient. Oral health professionals are encouraged to keep abreast of new
developments in this field and fully participate in the interdisciplinary care of this disease. Early
diagnosis and the fast institution of adequate therapy led our patient to achieve good results and
quality of life.
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